Cedar Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,919
| Closed | -$122K | – | 191 |
|
|
2025
Q4 | $122K | Hold |
4,919
| – | – | 0.04% | 99 |
|
|
2025
Q3 | $125K | Sell |
4,919
-681
| -12% | -$16.8K | 0.04% | 100 |
|
|
2025
Q2 | $136K | Buy |
5,600
+81
| +1% | +$1.89K | 0.05% | 89 |
|
|
2025
Q1 | $140K | Sell |
5,519
-219
| -4% | -$5.73K | 0.05% | 88 |
|
|
2024
Q4 | $152K | Buy |
5,738
+79
| +1% | +$2.14K | 0.06% | 79 |
|
|
2024
Q3 | $164K | Buy |
5,659
+71
| +1% | +$2.07K | 0.05% | 111 |
|
|
2024
Q2 | $156K | Sell |
5,588
-1,325
| -19% | -$36.5K | 0.05% | 114 |
|
|
2024
Q1 | $192K | Buy |
6,913
+946
| +16% | +$26.3K | 0.06% | 111 |
|
|
2023
Q4 | $172K | Buy |
5,967
+1,845
| +45% | +$55.8K | 0.06% | 109 |
|
|
2023
Q3 | $137K | Buy |
4,122
+267
| +7% | +$9.44K | 0.05% | 121 |
|
|
2023
Q2 | $141K | Buy |
3,855
+2,056
| +114% | +$80K | 0.05% | 117 |
|
|
2023
Q1 | $73.4K | Sell |
1,799
-1,030
| -36% | -$44.5K | 0.03% | 131 |
|
|
2022
Q4 | $145K | Hold |
2,829
| – | – | 0.07% | 101 |
|
|
2022
Q3 | $124K | Hold |
2,829
| – | – | 0.06% | 116 |
|
|
2022
Q2 | $148K | Hold |
2,829
| – | – | 0.07% | 116 |
|
|
2022
Q1 | $146K | Sell |
2,829
-833
| -23% | -$43.2K | 0.06% | 130 |
|
|
2021
Q4 | $216K | Buy |
3,662
+132
| +4% | +$6.54K | 0.09% | 119 |
|
|
2021
Q3 | $152K | Hold |
3,530
| – | – | 0.07% | 118 |
|
|
2021
Q2 | $138K | Sell |
3,530
-3,699
| -51% | -$144K | 0.06% | 124 |
|
|
2021
Q1 | $262K | Sell |
7,229
-1,601
| -18% | -$56.8K | 0.13% | 92 |
|
|
2020
Q4 | $325K | Sell |
8,830
-3,682
| -29% | -$135K | 0.17% | 77 |
|
|
2020
Q3 | $436K | Buy |
12,512
+10,551
| +538% | +$370K | 0.27% | 61 |
|
|
2020
Q2 | $61K | Buy |
1,961
+11
| +0.6% | +$374 | 0.04% | 120 |
|
|
2020
Q1 | $60K | Buy |
1,950
+1,054
| +118% | +$35.9K | 0.04% | 118 |
|
|
2019
Q4 | $33K | Buy |
896
+211
| +31% | +$7.52K | 0.02% | 106 |
|
|
2019
Q3 | $23K | Hold |
685
| – | – | 0.02% | 117 |
|
|
2019
Q2 | $28K | Hold |
685
| – | – | 0.02% | 126 |
|
|
2019
Q1 | $28K | Hold |
685
| – | – | 0.02% | 122 |
|
|
2018
Q4 | $28K | Hold |
685
| – | – | 0.02% | 102 |
|
|
2018
Q3 | $29K | Hold |
685
| – | – | 0.02% | 101 |
|
|
2018
Q2 | $24K | Hold |
685
| – | – | 0.01% | 99 |
|
|
2018
Q1 | $23K | Hold |
685
| – | – | 0.01% | 95 |
|
|
2017
Q4 | $24K | Hold |
685
| – | – | 0.01% | 95 |
|
|
2017
Q3 | $23K | Hold |
685
| – | – | 0.01% | 100 |
|
|
2017
Q2 | $22K | Hold |
685
| – | – | 0.01% | 99 |
|
|
2017
Q1 | $22K | Hold |
685
| – | – | 0.01% | 94 |
|
|
2016
Q4 | $21K | Hold |
685
| – | – | 0.01% | 95 |
|
|
2016
Q3 | $22K | Hold |
685
| – | – | 0.02% | 82 |
|
|
2016
Q2 | $23K | Sell |
685
-177
| -21% | -$5.65K | 0.01% | 90 |
|
|
2016
Q1 | $24K | Buy |
862
+685
| +387% | +$19.6K | 0.02% | 74 |
|
|
2015
Q4 | $5K | Buy |
+177
| New | +$5.57K | ﹤0.01% | 30 |
|
Other funds holding PFE
Cedar Wealth Management's PFE Position: Q1 2026 in Review
Cedar Wealth Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 4,919 shares — an estimated $122K sold.
Cedar Wealth Management first reported a position in PFE in Q4 2015 and held it in 41 quarters. The position peaked at $436K in Q3 2020. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Cedar Wealth Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Cedar Wealth Management sold 4,919 Pfizer shares in Q1 2026, an estimated $122K.
- Cedar Wealth Management first reported a position in Pfizer in Q4 2015 and held it in 41 quarters.
- Cedar Wealth Management's Pfizer position peaked at $436K in Q3 2020.
- 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Cedar Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.